Mutations in IDH1/2 have been found to have a significant impact on various types of human malignancies, including gliomas, acute myeloid leukemia, cholangiocarcinoma, ovarian cancer, and chondrosarcoma [7,8,9,10]. The gene discussed is IDH1; the disease is central nervous system cancer.